168 related articles for article (PubMed ID: 36135047)
1. Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study.
Bamias A; Tzannis K; Zakopoulou R; Sakellakis M; Dimitriadis J; Papatheodoridi A; Rallidis L; Halvatsiotis P; Tsiara A; Kaparelou M; Kostouros E; Barbarousi D; Koutsoukos K; Fragiadis E; Dellis AE; Anastasiou I; Stravodimos K; Pinitas A; Papatsoris A; Adamakis I; Varkarakis I; Fragoulis C; Pagoni S; Matsouka C; Skolarikos A; Mitropoulos D; Doumas K; Deliveliotis C; Constantinides C; Dimopoulos MA
Curr Oncol; 2022 Aug; 29(9):6077-6090. PubMed ID: 36135047
[TBL] [Abstract][Full Text] [Related]
2. Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy.
Bamias A; Tzannis K; Dimitriadis I; Tsironis G; Papatheorodidi AM; Tsiara A; Fragkoulis C; Xirokosta A; Barbarousi D; Papadopoulos G; Zakopoulou R; Varkarakis I; Mitsogiannis I; Adamakis I; Alamanis C; Stravodimos K; Papatsoris AG; Dellis AE; Drivalos A; Ntoumas K; Matsouka H; Halvatsiotis P; Raptis A; Gerotziafas GT; Dimopoulos MA
Clin Genitourin Cancer; 2020 Aug; 18(4):e457-e472. PubMed ID: 32007440
[TBL] [Abstract][Full Text] [Related]
3. A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy.
Zou PM; Li H; Cai JF; Chen ZJ; Li C; Xu P; Li MX; Chen LM; Li XM; Li XW
Chin Med Sci J; 2018 Jun; 33(2):91-99. PubMed ID: 29976278
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer.
Bamias A; Tzannis K; Bamia C; Harshman LC; Crabb S; Plimack ER; Pal S; De Giorgi U; Ladoire S; Theodore C; Agarwal N; Yu EY; Niegisch G; Sternberg CN; Srinivas S; Vaishampayan U; Necchi A; Liontos M; Rosenberg JE; Powles T; Bellmunt J; Galsky MD
Oncologist; 2019 Oct; 24(10):1348-1355. PubMed ID: 30936379
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Prognostic Implications of Readmissions Caused by Thrombotic Events After a Heart Failure Hospitalization.
Chaudhury P; Alvarez P; Michael M; Saad M; Bishop GJ; Hanna M; Menon V; Starling RC; Spyropoulos AC; Desai M; Mentias A
J Am Heart Assoc; 2022 May; 11(10):e025342. PubMed ID: 35535610
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis.
Qi WX; Lin F; Sun YJ; Tang LN; Shen Z; Yao Y
Br J Clin Pharmacol; 2013 Sep; 76(3):338-47. PubMed ID: 23834355
[TBL] [Abstract][Full Text] [Related]
7. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Bamias A; Tzannis K; Harshman LC; Crabb SJ; Wong YN; Kumar Pal S; De Giorgi U; Ladoire S; Agarwal N; Yu EY; Niegisch G; Necchi A; Sternberg CN; Srinivas S; Alva A; Vaishampayan U; Cerbone L; Liontos M; Rosenberg J; Powles T; Bellmunt J; Galsky MD;
Ann Oncol; 2018 Feb; 29(2):361-369. PubMed ID: 29077785
[TBL] [Abstract][Full Text] [Related]
8. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
[TBL] [Abstract][Full Text] [Related]
9. Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study.
Zhu J; Chen Y; Zhang Y; Wang W; Wang Y; Lu Z; Zhang Y; Lei H; Li D; Long B; Liu H
Cancer Med; 2023 Sep; 12(18):18531-18541. PubMed ID: 37584246
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
Mellema WW; van der Hoek D; Postmus PE; Smit EF
Lung Cancer; 2014 Oct; 86(1):73-7. PubMed ID: 25129368
[TBL] [Abstract][Full Text] [Related]
11. Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
Solinas C; Saba L; Sganzerla P; Petrelli F
Thromb Res; 2020 Dec; 196():444-453. PubMed ID: 33065409
[TBL] [Abstract][Full Text] [Related]
12. Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis.
Grilz E; Posch F; Nopp S; Königsbrügge O; Lang IM; Klimek P; Thurner S; Pabinger I; Ay C
Eur Heart J; 2021 Jun; 42(23):2299-2307. PubMed ID: 33769475
[TBL] [Abstract][Full Text] [Related]
13. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
Paffenholz P; Grein K; Heidegger I; Nestler T; Grabbert M; Salem J; Hellmich M; Pfister D; Heidenreich A
World J Urol; 2019 Sep; 37(9):1907-1916. PubMed ID: 30547197
[TBL] [Abstract][Full Text] [Related]
14. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Scappaticci FA; Skillings JR; Holden SN; Gerber HP; Miller K; Kabbinavar F; Bergsland E; Ngai J; Holmgren E; Wang J; Hurwitz H
J Natl Cancer Inst; 2007 Aug; 99(16):1232-9. PubMed ID: 17686822
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With Cancer.
Wang J; Kim YD; Kim CH
Mayo Clin Proc; 2021 Mar; 96(3):592-600. PubMed ID: 33673912
[TBL] [Abstract][Full Text] [Related]
16. Risk of atherothrombotic events in patients after proximal deep-vein thrombosis.
Pasha SM; Tan M; van Rees Vellinga TF; Klok FA; Huisman MV
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):13-8. PubMed ID: 25402192
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
[TBL] [Abstract][Full Text] [Related]
18. Arterial Thrombosis in Patients with Cancer.
Tuzovic M; Herrmann J; Iliescu C; Marmagkiolis K; Ziaeian B; Yang EH
Curr Treat Options Cardiovasc Med; 2018 Apr; 20(5):40. PubMed ID: 29627870
[TBL] [Abstract][Full Text] [Related]
19. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Sidney S; Cheetham TC; Connell FA; Ouellet-Hellstrom R; Graham DJ; Davis D; Sorel M; Quesenberry CP; Cooper WO
Contraception; 2013 Jan; 87(1):93-100. PubMed ID: 23083525
[TBL] [Abstract][Full Text] [Related]
20. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Moik F; Chan WE; Wiedemann S; Hoeller C; Tuchmann F; Aretin MB; Fuereder T; Zöchbauer-Müller S; Preusser M; Pabinger I; Ay C
Blood; 2021 Mar; 137(12):1669-1678. PubMed ID: 33067632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
